
- Telehealth Visits
- Insurance plan information
- Provider Type: Physician

Jessamyn Conell-Price, MD
Neurology- Telehealth Visits
- Insurance plan information
- Provider Type: Physician



Jessamyn Conell-Price, MD
NeurologyOn this page
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Residency
- Neurology, UCSF School of Medicine -GME
Internship
- Neurology, UCSF School of Medicine -GME
Degree
- MD, UCSF School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Locations
My work

Helping patients with puzzling neurological symptoms
My research
Publications
Showing 1-6 of 40 reviews
- September 10, 20264.4 out of 5 Stars
I did receive an email saying my portal had a post-visit summary, but the PVS was a one-liner saying I had been seen. I look forward to receiving patient instructions or a copy of the visit note someday.
- September 3, 20265 out of 5 Stars
Good experience
- September 2, 20265 out of 5 Stars
The doctor was extraordinary! Dry warm, caring, empathetic. Genuinely concerned about getting to the root of my problems
- August 27, 20265 out of 5 Stars
Very satisfied with the service of the nurses and doctors.
- June 22, 20264.9 out of 5 Stars
Dr, Conell-Price is one of the most caring, compassionate, thorough, and thoughtful doctors I have ever met. She answers all my questions and does her best to come up with a plan for my complex "case"/health. I am grateful she is my neurologist. I feel very fortunate to have her as one of my doctors.
- May 21, 20265 out of 5 Stars
Grateful that Dr. Connell-Price provides care options and has the humility to recommend others to check the care plan.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.